Explore more publications!

Press Releases

OilXCoin Launches Secondary Market Trading and Acquires O&G Lease in Kansas, USA
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
Swiss Serenity Publishes Comprehensive Guide on LPP Withdrawal for Swiss Expatriates: Withdrawal Rules and Administrative Aspects
OSCE training empowers young experts from Central Asia, South-East Europe and Mediterranean Partners for Co-operation regions in inclusive project design and digital research

OSCE training empowers young experts from Central Asia, South-East Europe and Mediterranean Partners for Co-operation regions in inclusive project design and digital research

Abaxx Technologies Acquires Strategic Position in ARTEX AG, Extending Capabilities in Europe and to New Markets in Fine Art
SEALSQ and Kaynes SemiCon Announce Joint Venture to Establish India's First Secure Semiconductor Center for Onshore Personalization and Quantum-Resistant Technology
Liechtenstein Bankers Association CEO Featured in CEO Insight: Driving Sustainable Finance and Innovation
Coatings And Application Technologies For Robotics Market To Reach $33.95 Billion By 2029 At 10.6% CAGR: TBRC
Open Cosmos Takes First Major Step Towards Its Low Earth Orbit Constellation With Landmark Satellite Launch
Krystal Biotech Announces European Commission Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
SEALSQ C-Suite Visits India to Advance Post-Quantum Semiconductor Personalization Center, Quantum Investments, and Sovereign Space Capabilities
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna
4BIO Capital Portfolio Company Araris Biotech to be Acquired by Taiho Pharmaceutical for up to USD 1.14 billion
AMERICAN SWISS FOUNDATION CO-HOSTS 2026 FRIENDSHIP COCKTAIL AT THE WORLD ECONOMIC FORUM
Introducing Obyte Friends: Rewards for Connections and Active Staking
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
CEO Insight Releases New 2026 Issue Examining Trust, Governance and Global Connectivity

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions